Method for identifying compounds modulating sister chromatid separation
AssigneeBoehringer Ingelheim International GmbH
InventorsJan-Michael Peters, Irene Waizenegger, Wolfgang Sommergruber
Life of this patent
Estimating the term…
Abstract
Screening methods for identifying separase inhibitors based on active forms of separase and compounds identified in such methods.
Claims10
A method for identifying a compound that has the ability of modulating sister chromatid separation by inhibiting the proteolytic activity of separase, characterized in that an active separase in the form of
- a) one or more separase fragment(s), optionally upon activation in the presence of securin, or
- b) the full-length separase upon activation in the presence of securin,
- is incubated in the presence of a separase substrate, with a test compound and that the modulating effect of the test compound on the proteolytic activity of the active separase is determined.
The method of claim, wherein the separase substrate is peptide that carries a fluorogenic group, which upon processing of the peptide results in a change in fluorescence and that the change in fluorescence is correlated with the separase activity.
A peptide selected from peptides containing the sequence DREIMR, SFEILR or EWELLR or a derivate thereof.
Dependencies are inferred from the claim text.